PLX
Protalix Biotherapeutics
Description:
Protalix Biotherapeutics Inc. is a biopharmaceutical company specializing in the development and commercialization of recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based protein expression system. Headquartered in Karmiel, Israel, Protalix's innovative approach allows for the production of complex proteins that treat various medical conditions, with a strategic focus on markets in Israel, Brazil, and Latin America. The company's commitment to advancing biotherapeutic solutions positions it as a key player in the biotech industry, catering to unmet medical needs globally.
Address:
2 UNIVERSITY PLAZA, HACKENSACK, NJ, UNITED STATES, 07601
Fiscal year end:
December
Market capitalization:
$194 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-81%
How much will you get:
$188
Prices dates:
30-09-2015: $11.80 and 30-09-2025: $2.22